These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9516963)

  • 1. Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
    Gibson AA; Harwood FG; Tillman DM; Houghton JA
    Clin Cancer Res; 1998 Jan; 4(1):145-52. PubMed ID: 9516963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 does not influence p53-mediated sensitivity to DNA-damaging drugs.
    McKenzie PP; McPake CR; Ashford AA; Vanin EF; Harris LC
    Mol Cancer Ther; 2002 Oct; 1(12):1097-104. PubMed ID: 12481433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
    Taylor AC; Schuster K; McKenzie PP; Harris LC
    Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective chemosensitization of rhabdomyosarcoma cell lines following wild-type p53 adenoviral transduction.
    Shetty S; Taylor AC; Harris LC
    Anticancer Drugs; 2002 Sep; 13(8):881-9. PubMed ID: 12394275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
    Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of exogenous wild-type p53 gene expression on sensitivity to chemotherapeutic agents in human lung cancer cell].
    Zhang H; Wang H; Lai B; Zhang C; Yang X
    Zhongguo Fei Ai Za Zhi; 2000 Jun; 3(3):166-9. PubMed ID: 20950542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.
    Bennicelli JL; Advani S; Schäfer BW; Barr FG
    Oncogene; 1999 Jul; 18(30):4348-56. PubMed ID: 10439042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
    Kempf BE; Vogt PK
    Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
    Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
    Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
    Guan B; Yue P; Clayman GL; Sun SY
    J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Arriola EL; Lopez AR; Chresta CM
    Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Baptiste N; Friedlander P; Chen X; Prives C
    Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma.
    Barr FG
    Cancer Res; 1999 Apr; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.
    McPake CR; Tillman DM; Poquette CA; George EO; Houghton JA; Harris LC
    Oncol Res; 1998; 10(5):235-44. PubMed ID: 9802058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
    Petak I; Tillman DM; Houghton JA
    Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
    Hosoi H; Dilling MB; Shikata T; Liu LN; Shu L; Ashmun RA; Germain GS; Abraham RT; Houghton PJ
    Cancer Res; 1999 Feb; 59(4):886-94. PubMed ID: 10029080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.